In vivo studies in rodent models with type 1 and type 2 diabetes have shown that β-cell-specific Trx1 overexpression inhibits their death and slows the progression for type 1 diabetes [175,176]. This evidence concerns the gene TXN and type 2 diabetes mellitus.